The global hemophilia A treatment paradigm has experienced unprecedented disruption through Hemlibra, which continues setting industry benchmarks for subcutaneous prophylactic interventions. This transformative medication has revolutionized therapeutic standards through its unique administration methodology and superior clinical efficacy profiles. Financial analyses project hemlibra 2025 sales...